• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

少突胶质细胞瘤和弥漫性星形细胞瘤复发的临床病理特征。

Clinicopathological features in the recurrence of oligodendroglioma and diffuse astrocytoma.

机构信息

Department of Neurosurgery, Faculty of Medical Sciences, University of Fukui, Eiheiji, Japan.

出版信息

Brain Tumor Pathol. 2012 Jul;29(3):140-7. doi: 10.1007/s10014-012-0104-2. Epub 2012 May 31.

DOI:10.1007/s10014-012-0104-2
PMID:22648019
Abstract

To investigate whether grade II oligodendroglioma was transformed to glioblastoma or not, histopathological evaluation of recurrent oligodendrogliomal tumors (OG) and diffuse astrocytomas (DA) was performed. The OG group was composed of ten patients with OG, including seven oligodendrogliomas and three oligoastrocytomas. The DA group was composed of ten patients with DA, including eight fibrillary astrocytomas and two gemistocytic astrocytomas. The histopathological parameters of glioblastoma including nuclear atypia, multinucleated giant cells, glomeruloid tufts (GT) as a marker of microvascular proliferation, necrosis, and the Ki-67 staining index were investigated. Evaluation of these parameters was scored as follows: 0, none; 1, sporadic; 2, partial; 3, extensive. There were no cases of transformation to glioblastoma in the OG group. There were five cases of transformation to secondary glioblastoma in the DA group. In recurrent tumors, scores of GT and necrosis in the OG group were significantly lower than those in the DA group (p < 0.005). Nuclear atypia and high proliferative activity (Ki-67 index) were identified in recurrent tumors of the OG group. Our study suggested that the extent of GT and necrosis in recurrent OG was less than that in recurrent DA, and transformation to glioblastoma from oligodendroglial tumor was exceptional.

摘要

为了研究二级少突胶质细胞瘤是否转化为胶质母细胞瘤,对复发性少突胶质细胞瘤(OG)和弥漫性星形细胞瘤(DA)进行了组织病理学评估。OG 组由 10 名 OG 患者组成,包括 7 名少突胶质细胞瘤和 3 名少突星形细胞瘤。DA 组由 10 名 DA 患者组成,包括 8 名纤维状星形细胞瘤和 2 名胶质细胞瘤。研究了胶质母细胞瘤的核异型性、多核巨细胞、肾小球样簇(GT)作为微血管增殖的标志物、坏死和 Ki-67 染色指数等组织病理学参数。这些参数的评估评分如下:0,无;1,散在;2,部分;3,广泛。OG 组无一例转化为胶质母细胞瘤。DA 组有 5 例转化为继发性胶质母细胞瘤。在复发性肿瘤中,OG 组的 GT 和坏死评分明显低于 DA 组(p<0.005)。OG 组复发性肿瘤中存在核异型性和高增殖活性(Ki-67 指数)。本研究表明,复发性 OG 中的 GT 和坏死程度低于复发性 DA,从少突胶质细胞瘤转化为胶质母细胞瘤是例外的。

相似文献

1
Clinicopathological features in the recurrence of oligodendroglioma and diffuse astrocytoma.少突胶质细胞瘤和弥漫性星形细胞瘤复发的临床病理特征。
Brain Tumor Pathol. 2012 Jul;29(3):140-7. doi: 10.1007/s10014-012-0104-2. Epub 2012 May 31.
2
Glioblastoma with oligodendroglial components: glioblastoma or anaplastic oligodendroglial tumors.伴少突胶质细胞成分的胶质母细胞瘤:胶质母细胞瘤还是间变性少突胶质细胞瘤。
Brain Tumor Pathol. 2012 Jul;29(3):154-9. doi: 10.1007/s10014-012-0100-6. Epub 2012 Apr 12.
3
Evaluation of malignant features in oligodendroglial tumors.少突胶质细胞瘤恶性特征的评估
Clin Neuropathol. 1999 Mar-Apr;18(2):61-73.
4
Clinicohistological study of oligodendroglioma and oligoastrocytoma.少突胶质细胞瘤和少突星形细胞瘤的临床组织学研究
Brain Tumor Pathol. 1997;14(1):35-9. doi: 10.1007/BF02478866.
5
The expression of cell cycle regulatory proteins in oligodendroglial tumors.少突胶质细胞瘤中细胞周期调节蛋白的表达
Clin Neuropathol. 2002 Mar-Apr;21(2):52-65.
6
Early prognostic factors related to progression and malignant transformation of low-grade gliomas.与低级别胶质瘤进展和恶性转化相关的早期预后因素。
Clin Neurol Neurosurg. 2011 Nov;113(9):752-7. doi: 10.1016/j.clineuro.2011.08.002. Epub 2011 Sep 1.
7
Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas.基于人群的低级别弥漫性星形细胞瘤和少突胶质细胞瘤的发病率、生存率及基因改变研究。
Acta Neuropathol. 2004 Jul;108(1):49-56. doi: 10.1007/s00401-004-0861-z. Epub 2004 Apr 28.
8
Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.胶质瘤中1p36和19q13的等位基因缺失:与组织学分类的相关性、1p36上150kb最小缺失区域的定义以及CAMTA1作为候选肿瘤抑制基因的评估
Clin Cancer Res. 2005 Feb 1;11(3):1119-28.
9
Pleiotrophin expression in astrocytic and oligodendroglial tumors and it's correlation with histological diagnosis, microvascular density, cellular proliferation and overall survival.多效生长因子在星形胶质细胞瘤和少突胶质细胞瘤中的表达及其与组织学诊断、微血管密度、细胞增殖和总生存期的相关性。
J Neurooncol. 2007 Sep;84(3):255-61. doi: 10.1007/s11060-007-9379-2. Epub 2007 Apr 19.
10
Clarifying the diffuse gliomas: an update on the morphologic features and markers that discriminate oligodendroglioma from astrocytoma.解析弥漫性胶质瘤:鉴别少突胶质细胞瘤与星形细胞瘤的形态学特征和标志物的最新进展
Am J Clin Pathol. 2005 Nov;124(5):755-68. doi: 10.1309/6JNX-4PA6-0TQ5-U5VG.

引用本文的文献

1
A strategy for multimodal integration of transcriptomics, proteomics, and radiomics data for the prediction of recurrence in patients with IDH-mutant gliomas.一种用于整合转录组学、蛋白质组学和放射组学数据以预测异柠檬酸脱氢酶(IDH)突变型胶质瘤患者复发情况的多模态策略。
Int J Cancer. 2025 Aug 1;157(3):573-587. doi: 10.1002/ijc.35441. Epub 2025 Apr 11.